Erleada 60mg Tablet
Rx RequiredSalt Composition: Apalutamide
Expiry Date: 01/2028
Price on Request
Inclusive of all taxes
120 Tablet in Bottle
About The Product
Prostate Cancer
Erleada 60mg Tablet is used in the treatment of non‑metastatic castration‑resistant prostate cancer. This drug is given to patients who are diagnosed with early-stage cancer. Erleada lowers the secretion of male sex hormones by inhibiting the enzyme. Eventually, it prevents cancer cells from spreading to other body parts. Erleada 60mg Tablet is usually taken with a steroid to lower the side effects of other anticancer medicines.
Description
Erleada 60mg Tablet is a prescription-based antineoplastic drug. Doctors prescribe this drug to treat early-stage non‑metastatic castration‑resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.
Erleada 60mg tablet is also given to treat metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT). This drug restricts the normal secretion of male sex hormones by inhibiting the actions of the enzyme.
In this way, it stops the multiplication of the prostate cancer cells in the nearby organs. Your healthcare provider will decide how much you take and how often you need this tablet.
You are advised to follow the prescription strictly. You should take Erleada 60mg Tablet until your doctor says to do so.
Erleada 60mg Tablet also relaxes the associated symptoms of prostate cancer, such as difficulty in passing the urine. Inform your doctor if you are taking any prescribed and non-prescribed medications.
These medicines can interact with Erleada 60mg Tablet and may result in some undesirable effects. Erleada 60mg Tablet should not be given to pregnant and breastfeeding women, as it may pass through the mother and harm the baby.
Side Effects
Like other anticancer medicines, Erleada 60mg Tablet has some mild to severe side effects. These are undesired symptoms observed in the body after taking this tablet. Usually, they disappear with time as the body adjusts to the medicine. These adverse effects don't need special medical attention, but if you observe them continually, talk to your medical expert. Some of them are listed below:
Common side effects
Fatigue
Joint and muscle pain
Loss of appetite
Rashes and itching on the skin
High blood pressure
Swelling
Hot flashes
Weight loss
Diarrhea
Broken bone
Vomiting and nausea
Severe side effects
Dizziness & sweating
Trouble with speaking
Problem in vision
Chest pain and faster heart rate
Difficulty in normal breathing
Severe skin allergic reactions
Lung inflammation
How To Use
- Erleada 60mg Tablet is a prescription-based anticancer drug that should be administered orally.
- It is advised to take this tablet after consulting your healthcare expert.
How It Works
Erleada 60mg Tablet is an anticancer medication consisting of a salt ingredient known as Apalutamide. This medicine acts by preventing androgen (male hormone) production in males.
It inhibits an enzyme known as CYP17, which is responsible for androgen production. This process slows down the multiplication rate and stops the progression of prostate cancer.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Erleada 60mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
Erleada 60mg Tablet is an anticancer medication consisting of a salt ingredient known as Apalutamide. Erleada 60mg Tablet is used to treat prostate cancer in men. So, it is not safe to use for women and children.
Your healthcare expert must measure your blood sugar & pressure, potassium level, and liver function tests at regular intervals. Taking the Erleada 60mg Tablet can cause fluctuations in their levels.
Inform your doctor if you have diabetes or any heart, liver, or kidney problems before taking Erleada 60mg Tablet.
Use reliable methods of birth control and contraceptive pills to delay pregnancy while under treatment with Erleada 60mg Tablet. Discuss with your healthcare expert the risks and benefits of taking this medicine if you want to conceive in the future.
Erleada is not recommended in patients with a history of seizures, any brain injury, or a recent stroke (within one year).
FAQs
Your healthcare provider will decide how much you take and how often you need this tablet. You are advised to follow the prescription strictly.
You should take Erleada 60mg Tablet until your doctor says to do so.
Reference
Yu, A., & Ackaert, O. (2023).
Bioequivalence clinical trial simulation: a case study of apalutamide administered in applesauce versus whole tablets. AAPS Open, 9(1), 15.
Tohi, Y., Kobayashi, K., Daizumoto, K., Sekino, Y., Fukuhara, H., Niigawa, H., & Sugimoto, M. (2025).
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC. Japanese Journal of Clinical Oncology, 55(6), 643-649.
Nguyen, M. D., Modestine, J.
R. D., Djoua, Y., Gorobets, O., Vinh-Hung, V. & Verschraegen, C.
F. (2025).
Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series. Anticancer Research, 45(7), 3127-3136.
Boegemann, M., Bennamoun, M., Dourthe, L. M.
Encarnacion, J. A., Hegele, A., Hellmis, E. & Kramer, G.
(2025). Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.
BMC cancer, 25(1), 1119. Yue, W., Li, C., Wang, T., You, J., Sun, J., Liu, J., & Padanilam, B.
J. (2025).
Circadian rhythm-related miR-6883-5p suppresses enzalutamide-resistant prostate cancer. Non-coding RNA Research.
Roy, S., Malone, S., Wing, K., Chowdhury, S., Kishan, A. U., Sun, Y., & Saad, F.
(2024). Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical Trial.
JAMA network open, 7(10), e2439434-e2439434.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
